FemPulse Pivotal Study Selected For Presentation at the American Urological Association Annual Conference
SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) — FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB),…
